DISEASE SCANNER
Global Incurable Diseases Tracker
Narcolepsy
A chronic neurological sleep disorder characterized by dysregulation of sleep-wake cycles. Type 1 (with cataplexy, hypocretin deficiency) and Type 2. Often triggered by environmental factors in genetically susceptible individuals (HLA-DQB1*06:02).
3.0M
15
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1Neurological examination
- 2MRI/CT imaging
- 3EEG
- 4EMG/NCV
- 5Lumbar puncture
- 6Genetic testing
- 7Neuropsychological testing
Prognosis
Lifelong condition with no cure. Symptoms typically stable after initial onset period. Type 1 (with cataplexy) tends to have more severe symptoms than Type 2. Sodium oxybate dramatically improves nighttime sleep and reduces daytime sleepiness. Stimulants and wake-promoting agents manage EDS. Scheduled naps help. Safety concerns for driving and operating machinery. Psychosocial support important. Normal life expectancy with treatment. Some evidence of increased cardiovascular risk.
Prevention
- Head protection
- Cardiovascular health
- Cognitive stimulation
- Physical exercise
- Healthy diet
- Avoidance of toxins
- Regular monitoring
Research Status
Sodium oxybate (Xyrem/Xywav), pitolisant (H3 antagonist), solriamfetol (DNRI), and modafinil/armodafinil effective. Immunotherapy (intravenous immunoglobulin) may benefit recent onset. Gene therapy research ongoing.
Affected Countries
Sources
- https://www.ncbi.nlm.nih.gov/books/NBK539800
- https://www.ncbi.nlm.nih.gov/books
- https://www.mayoclinic.org/diseases-conditions
- https://rarediseases.org/rare-diseases
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.